SCHEMBL15929413

SCHEMBL15929413

CCNC12CNCCNCC(NCc3ccc(C(=O)ON4C(=O)CCC4=O)cc3)(CNCCNC1)CNCCNC2

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 4/20 0.34
LMNA P02545 3/20 0.34
HDAC8 Q9BY41 3/20 0.34
RAB9A P51151 2/20 0.34
HTT P42858 2/20 0.34
NPC1 O15118 1/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 2/20 0.32
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
LOXL2 Q9Y4K0 1/20 0.32
GAA P10253 1/20 0.31
RECQL P46063 1/20 0.31
HDAC1 Q13547 2/20 0.31
SSTR3 P32745 1/20 0.31
HDAC3 O15379 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15928049 0.94 HDAC6 (0.36) HDAC6LMNAHDAC8RAB9AHTT
SCHEMBL15929457 0.92 HDAC6 (0.34) HDAC6LMNAHDAC8RAB9AHTT
SCHEMBL15928056 0.89 HDAC6 (0.33) HDAC6LMNAHDAC8RAB9AHTT
SCHEMBL22488653 0.79 SMN1; SMN2 (0.31) LMNARAB9AHTTNPC1HPGD
SCHEMBL17071632 0.75 ALDH1A1 (0.47) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL3418246 0.74 LOXL2 (0.49) HDAC6LMNAHDAC8RAB9AHTT
SCHEMBL17787294 0.73 KMT2A (0.53) HDAC6HDAC8RAB9AHTTKMT2A
SCHEMBL26167885 0.72 ADRB2 (0.41) HDAC6LMNARAB9AHTTNPC1
SCHEMBL15929409 0.71 MGLL (0.48) LMNAHTTHPGDALDH1A1RECQL
SCHEMBL22479280 0.71 MEN1 (0.38) LMNAKMT2AMEN1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542267-B2 Cryptate compounds AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2023-01-03 US disclosed
US-20200308182-A1 CRYPTATE COMPOUNDS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2020-10-01 US disclosed
US-10717741-B2 Cryptate compounds AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2020-07-21 US disclosed
US-20140219915-A1 CRYPTATE COMPOUNDS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140219915-A1 CRYPTATE COMPOUNDS HCCS, SQOR, NQO1 HDAC6 613/4885LMNA 2573/4885HDAC8 618/4885
US-11542267-B2 Cryptate compounds HCCS, SQOR, NQO1 HDAC6 613/4885LMNA 2573/4885HDAC8 618/4885
US-20200308182-A1 CRYPTATE COMPOUNDS HCCS, SQOR, NQO1 HDAC6 613/4885LMNA 2573/4885HDAC8 618/4885
US-10717741-B2 Cryptate compounds HCCS, SQOR, NQO1 HDAC6 613/4885LMNA 2573/4885HDAC8 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.